GADOBUTROL
Gadavist was approved for use in Cardiac MRI imaging and for patients at risk for NSF and retention of GBCAs at the August 2018 P&T Committee meeting.
Gadavist was approved for use in Cardiac MRI imaging and for patients at risk for NSF and retention of GBCAs at the August 2018 P&T Committee meeting.